MiR-130a-3p suppresses colorectal cancer growth by targeting Wnt Family Member 1 (WNT1)

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Meyerhardt JA, Mayer RJ. Systemic therapy for colorectal cancer. N Engl J Med. 2005;352(5):4044–4053.
   PubMed Web of Science ®Google Scholar
• O’Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst. 2004;96(19):1420–1425.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–233.
   PubMed Web of Science ®Google Scholar
• Hatley ME, Patrick DM, Garcia MR, et al. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell. 2010;18(3):282–293.
   PubMed Web of Science ®Google Scholar
• D’Urso PI, D’Urso OF, Storelli C, et al. miR-155 is up-regulated in primary and secondary glioblastoma and promotes tumour growth by inhibiting GABA receptors. Int J Oncol. 2012;41:228–234.
   PubMed Web of Science ®Google Scholar
• He XX, Chang Y, Meng FY, et al. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene. 2012;31(28):3357–3369.
   PubMed Web of Science ®Google Scholar
• Iida M, Hazama S, Tsunedomi R, et al. Overexpression of miR221 and miR222 in the cancer stroma is associated with malignant potential in colorectal cancer. Oncol Rep. 2018 Sep;40(3):1621–1631
   PubMedGoogle Scholar
• Takamizawa J, Konishi H, Yanagisawa K, et al. Reduced Expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004;64(11):3753–3756.
   PubMed Web of Science ®Google Scholar
• Li Z, Cao Y, Jie Z, et al. miR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3. Cancer Lett. 2012;323(1):41–47.
   PubMed Web of Science ®Google Scholar
• Suresh S, McCallum L, Lu W, et al. MicroRNAs 130a/b are regulated by BCR-ABL and downregulate expression of CCN3 in CML. J Cell Commun Signal. 2011;5(3):183–191.
   PubMed Web of Science ®Google Scholar
• Kong X, Zhang J, Li J, et al. MiR-130a-3p inhibits migration and invasion by regulating RAB5B in human breast cancer stem cell-like cells. Biochem Biophys Res Commun. 2018;501(2):486–493.
   PubMed Web of Science ®Google Scholar
• Chen X, Yue B, Zhang C, et al. MiR-130a-3p inhibits the viability, proliferation, invasion, and cell cycle, and promotes apoptosis of nasopharyngeal carcinoma cells by suppressing BACH2 expression. Biosci Rep. 2017Jun 8;37(3):BSR20160576.
   Web of Science ®Google Scholar
• Qu R, Sun Y, Li Y, et al. MicroRNA-130a-3p suppresses cell viability, proliferation and invasion in nasopharyngeal carcinoma by inhibiting CXCL12. Am J Transl Res. 2017;9:3586–3598.
   PubMed Web of Science ®Google Scholar
• Wang S, Han H, Hu Y, et al. MicroRNA-130a-3p suppresses cell migration and invasion by inhibition of TBL1XR1-mediated EMT in human gastric carcinoma. Mol Carcinog. 2018;57(3):383–392.
   PubMed Web of Science ®Google Scholar
• Kara M, Yumrutas O, Ozcan O, et al. Differential expressions of cancer-associated genes and their regulatory miRNAs in colorectal carcinoma. Gene. 2015;567(1):81–86.
   PubMed Web of Science ®Google Scholar
• Liu J, Pan S, Sun F, et al. PD08-11: targeting porcupine, a critical node for Wnt signalling in cancer. Cancer Res. 2011;71:PD08–11.
   PubMed Web of Science ®Google Scholar
• Zhang W, Sun Z, Su L, et al. miRNA-185 serves as a prognostic factor and suppresses migration and invasion through Wnt1 in colon cancer. Eur J Pharmacol. 2018;825:75–84.
   PubMed Web of Science ®Google Scholar
• Ai L, Luo X, Yan X, et al. MicroRNA-506-3p inhibits colorectal cancer cell proliferation through targeting enhancer of zeste homologue 2. Bioengineered. 2021;12(1):4044–4053.
   PubMed Web of Science ®Google Scholar
• Karimi L, Zeinali T, Hosseinahli N, et al. miRNA-143 replacement therapy harnesses the proliferation and migration of colorectal cancer cells in vitro. J Cell Physiol. 2019;234(11):21359–21368.
   PubMed Web of Science ®Google Scholar
• Mansoori B, Mohammadi A, Naghizadeh S, et al. miR-330 suppresses EMT and induces apoptosis by downregulating HMGA2 in human colorectal cancer. J Cell Physiol. 2020;235(2):920–931.
   PubMed Web of Science ®Google Scholar
• Liang Z, Li X, Liu S, et al. MiR-141–3p inhibits cell proliferation, migration and invasion by targeting TRAF5 in colorectal cancer. Biochem Biophys Res Commun. 2019;514(3):699–705.
   PubMed Web of Science ®Google Scholar
• Zhang L, Li C, Cao L, et al. microRNA-877 inhibits malignant progression of colorectal cancer by directly targeting MTDH and regulating the PTEN/Akt pathway. Cancer Manag Res. 2019;11:2769–2781.
   PubMed Web of Science ®Google Scholar
• Tian X, Fei Q, Du M, et al. miR-130a-3p regulated TGF-β1-induced epithelial-mesenchymal transition depends on SMAD4 in EC-1 cells. Cancer Med. 2019;8(3):1197–1208.
   PubMed Web of Science ®Google Scholar
• Asukai K, Kawamoto K, Eguchi H, et al. Micro-RNA-130a-3p Regulates Gemcitabine Resistance via PPARG in Cholangiocarcinoma. Ann Surg Oncol. 2017;24(8):2344–2352.
   PubMed Web of Science ®Google Scholar
• Ouyang M, Li Y, Ye S, et al. MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer. PLoS One. 2014;9(5):e96228.
   PubMed Web of Science ®Google Scholar
• Wang M, Wang X, Liu W. MicroRNA‑130a‑3p promotes the proliferation and inhibits the apoptosis of cervical cancer cells via negative regulation of RUNX3. Mol Med Rep. 2020;22:2990–3000.
   PubMed Web of Science ®Google Scholar
• Prosperi JR, Goss KH. A Wnt-ow of Opportunity: targeting the Wnt/β-Catenin pathway in breast cancer. Curr Drug Targets. 2010;11(9):2344–2352.
   PubMed Web of Science ®Google Scholar
• Khramtsov AI, Khramtsova GF, Tretiakova M, et al. Wnt/β-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. Am J Pathol. 2010;176(6):1074–1088.
   PubMed Web of Science ®Google Scholar
• Clevers H. Wnt/β-catenin signaling in development and disease. Cell. 2006;127(3):469–480.
   PubMed Web of Science ®Google Scholar
• Polakis P. The many ways of Wnt in cancer. Curr Opin Genet Dev. 2007;17(1):45–51.
   PubMed Web of Science ®Google Scholar
• Poodineh J, Sirati-Sabet M, Rajabibazl M, et al. MiR-130a-3p blocks Wnt signaling cascade in the triple-negative breast cancer by targeting the key players at multiple points. Heliyon. 2020;6(11):e05434.
   PubMed Web of Science ®Google Scholar
• Tetsu O, McCormick F. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398(6726):422–426.
   PubMed Web of Science ®Google Scholar
• Chen W, Zhang YW, Li Y, et al. Constitutive expression of Wnt/β-catenin target genes promotes proliferation and invasion of liver cancer stem cells. Mol Med Rep. 2016;13(4):3466–3474.
   PubMed Web of Science ®Google Scholar